These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 30155665)
1. Use of nitroglycerin ointment to treat primary and secondary Raynaud's phenomenon: a systematic literature review. Qiu O; Chan T; Luen M; Cruz JE; Hermes-DeSantis ER Rheumatol Int; 2018 Dec; 38(12):2209-2216. PubMed ID: 30155665 [TBL] [Abstract][Full Text] [Related]
2. MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial. Chung L; Shapiro L; Fiorentino D; Baron M; Shanahan J; Sule S; Hsu V; Rothfield N; Steen V; Martin RW; Smith E; Mayes M; Simms R; Pope J; Kahaleh B; Csuka ME; Gruber B; Collier D; Sweiss N; Gilbert A; Dechow FJ; Gregory J; Wigley FM Arthritis Rheum; 2009 Mar; 60(3):870-7. PubMed ID: 19248104 [TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of the effects of topical nitrates in the treatment of primary and secondary Raynaud's phenomenon. Curtiss P; Schwager Z; Cobos G; Lo Sicco K; Franks AG J Am Acad Dermatol; 2018 Jun; 78(6):1110-1118.e3. PubMed ID: 29408338 [TBL] [Abstract][Full Text] [Related]
4. Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis. Anderson ME; Moore TL; Hollis S; Jayson MI; King TA; Herrick AL Rheumatology (Oxford); 2002 Mar; 41(3):324-8. PubMed ID: 11934971 [TBL] [Abstract][Full Text] [Related]
5. Sustained-release transdermal glyceryl trinitrate patches as a treatment for primary and secondary Raynaud's phenomenon. Teh LS; Manning J; Moore T; Tully MP; O'Reilly D; Jayson MI Br J Rheumatol; 1995 Jul; 34(7):636-41. PubMed ID: 7670782 [TBL] [Abstract][Full Text] [Related]
6. Reduced perfusion in systemic sclerosis digital ulcers (both fingertip and extensor) can be increased by topical application of glyceryl trinitrate. Hughes M; Moore T; Manning J; Wilkinson J; Dinsdale G; Roberts C; Murray A; Herrick AL Microvasc Res; 2017 May; 111():32-36. PubMed ID: 28027937 [TBL] [Abstract][Full Text] [Related]
7. Therapy: A local approach to Raynaud phenomenon. Herrick AL Nat Rev Rheumatol; 2009 May; 5(5):246-7. PubMed ID: 19412190 [TBL] [Abstract][Full Text] [Related]
8. Raynaud's phenomenon and digital ischaemia--pharmacologic approach and alternative treatment options. Linnemann B; Erbe M Vasa; 2016; 45(3):201-12. PubMed ID: 27129065 [TBL] [Abstract][Full Text] [Related]
9. Topical nitroglycerin ointment in Raynaud's phenomenon. Fischer M; Reinhold B; Falck H; Török M; Alexander K Z Kardiol; 1985 May; 74(5):298-302. PubMed ID: 3925656 [TBL] [Abstract][Full Text] [Related]
10. Topical glyceryl trinitrate as adjunctive treatment in Raynaud's disease. Franks AG Lancet; 1982 Jan; 1(8263):76-7. PubMed ID: 6119495 [TBL] [Abstract][Full Text] [Related]
12. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476 [TBL] [Abstract][Full Text] [Related]
13. Perianal versus endoanal application of glyceryl trinitrate 0.4% ointment in the treatment of chronic anal fissure: results of a randomized controlled trial. Is this the solution to the headaches? Pérez-Legaz J; Arroyo A; Moya P; Ruiz-Tovar J; Frangi A; Candela F; Oliver MI; Calpena R Dis Colon Rectum; 2012 Aug; 55(8):893-9. PubMed ID: 22810476 [TBL] [Abstract][Full Text] [Related]
15. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy. Fries R; Shariat K; von Wilmowsky H; Böhm M Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885 [TBL] [Abstract][Full Text] [Related]
16. [Local treatment of anal fissure with nitroglycerin ointment]. Osterwald-Lenum NS; Rosenberg J; Bülow S Ugeskr Laeger; 1998 Aug; 160(36):5211-4. PubMed ID: 9741288 [No Abstract] [Full Text] [Related]
17. A retrospective clinical analysis of pharmacological modalities used for symptomatic relief of Raynaud's phenomenon in children treated in a UK paediatric rheumatology centre. Gargh K; Baildam EM; Cleary GA; Beresford MW; McCann LJ Rheumatology (Oxford); 2010 Jan; 49(1):193-4. PubMed ID: 19797310 [No Abstract] [Full Text] [Related]
18. A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon. Hummers LK; Dugowson CE; Dechow FJ; Wise RA; Gregory J; Michalek J; Yenokyan G; McGready J; Wigley FM Ann Rheum Dis; 2013 Dec; 72(12):1962-7. PubMed ID: 23268365 [TBL] [Abstract][Full Text] [Related]